These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 20615489

  • 1. Fragments of antigen-loaded dendritic cells (DC) and DC-derived exosomes induce protective immunity against Leishmania major.
    Schnitzer JK, Berzel S, Fajardo-Moser M, Remer KA, Moll H.
    Vaccine; 2010 Aug 16; 28(36):5785-93. PubMed ID: 20615489
    [Abstract] [Full Text] [Related]

  • 2. Vaccination with plasmacytoid dendritic cells induces protection against infection with Leishmania major in mice.
    Remer KA, Apetrei C, Schwarz T, Linden C, Moll H.
    Eur J Immunol; 2007 Sep 16; 37(9):2463-73. PubMed ID: 17705130
    [Abstract] [Full Text] [Related]

  • 3. Induction of protective immunity against Eimeria tenella infection using antigen-loaded dendritic cells (DC) and DC-derived exosomes.
    Del Cacho E, Gallego M, Lee SH, Lillehoj HS, Quilez J, Lillehoj EP, Sánchez-Acedo C.
    Vaccine; 2011 May 12; 29(21):3818-25. PubMed ID: 21439315
    [Abstract] [Full Text] [Related]

  • 4. Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB/c mice against Leishmania major infection.
    Hugentobler F, Di Roberto RB, Gillard J, Cousineau B.
    Vaccine; 2012 Aug 24; 30(39):5726-32. PubMed ID: 22814408
    [Abstract] [Full Text] [Related]

  • 5. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response.
    Moll H, Flohé S, Röllinghoff M.
    Eur J Immunol; 1995 Mar 24; 25(3):693-9. PubMed ID: 7705398
    [Abstract] [Full Text] [Related]

  • 6. CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis.
    Ritter U, Meissner A, Scheidig C, Körner H.
    Eur J Immunol; 2004 Jun 24; 34(6):1542-50. PubMed ID: 15162423
    [Abstract] [Full Text] [Related]

  • 7. Dendritic cell (DC)-based protection against an intracellular pathogen is dependent upon DC-derived IL-12 and can be induced by molecularly defined antigens.
    Berberich C, Ramírez-Pineda JR, Hambrecht C, Alber G, Skeiky YA, Moll H.
    J Immunol; 2003 Mar 15; 170(6):3171-9. PubMed ID: 12626575
    [Abstract] [Full Text] [Related]

  • 8. Leishmania exosomes modulate innate and adaptive immune responses through effects on monocytes and dendritic cells.
    Silverman JM, Clos J, Horakova E, Wang AY, Wiesgigl M, Kelly I, Lynn MA, McMaster WR, Foster LJ, Levings MK, Reiner NE.
    J Immunol; 2010 Nov 01; 185(9):5011-22. PubMed ID: 20881185
    [Abstract] [Full Text] [Related]

  • 9. Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c mice.
    Tonui WK, Mbati PA, Anjili CO, Orago AS, Turco SJ, Githure JI, Koech DK.
    East Afr Med J; 2001 Feb 01; 78(2):90-2. PubMed ID: 11682953
    [Abstract] [Full Text] [Related]

  • 10. Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells.
    Bertholet S, Debrabant A, Afrin F, Caler E, Mendez S, Tabbara KS, Belkaid Y, Sacks DL.
    Infect Immun; 2005 Oct 01; 73(10):6620-8. PubMed ID: 16177338
    [Abstract] [Full Text] [Related]

  • 11. Invariant NKT cells preferentially modulate the function of CD8 alpha+ dendritic cell subset in inducing type 1 immunity against infection.
    Joyee AG, Uzonna J, Yang X.
    J Immunol; 2010 Feb 15; 184(4):2095-106. PubMed ID: 20089704
    [Abstract] [Full Text] [Related]

  • 12. Protection of susceptible BALB/c mice from challenge with Leishmania major by nucleoside hydrolase, a soluble exo-antigen of Leishmania.
    Al-Wabel MA, Tonui WK, Cui L, Martin SK, Titus RG.
    Am J Trop Med Hyg; 2007 Dec 15; 77(6):1060-5. PubMed ID: 18165522
    [Abstract] [Full Text] [Related]

  • 13. Protective immune responses induced by vaccination with an expression genomic library of Leishmania major.
    Piedrafita D, Xu D, Hunter D, Harrison RA, Liew FY.
    J Immunol; 1999 Aug 01; 163(3):1467-72. PubMed ID: 10415048
    [Abstract] [Full Text] [Related]

  • 14. Selective down-regulation of Th2 immune responses following treatment with antigen-coupled splenocytes.
    Soldera S, McSorley SJ, Glaichenhaus N.
    Eur J Immunol; 1997 Apr 01; 27(4):848-54. PubMed ID: 9130634
    [Abstract] [Full Text] [Related]

  • 15. The immunogenicity of dendritic cell-derived exosomes.
    Quah BJ, O'Neill HC.
    Blood Cells Mol Dis; 2005 Apr 01; 35(2):94-110. PubMed ID: 15975838
    [Abstract] [Full Text] [Related]

  • 16. Dendritic cell-based vaccination strategies: induction of protective immunity against leishmaniasis.
    Moll H, Berberich C.
    Immunobiology; 2001 Dec 01; 204(5):659-66. PubMed ID: 11846231
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of vaccination with a combination of Leishmania amastigote antigens and the lipid A-analogue ONO-4007 for immunoprophylaxis and immunotherapy against Leishmania amazonensis infection in a murine model of New World cutaneous leishmaniasis.
    Calvopina M, Barroso PA, Marco JD, Korenaga M, Cooper PJ, Nonaka S, Hashiguchi Y.
    Vaccine; 2006 Jul 07; 24(27-28):5645-52. PubMed ID: 16621179
    [Abstract] [Full Text] [Related]

  • 18. Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis.
    Iborra S, Soto M, Carrión J, Alonso C, Requena JM.
    Vaccine; 2004 Sep 28; 22(29-30):3865-76. PubMed ID: 15364433
    [Abstract] [Full Text] [Related]

  • 19. Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice.
    Iborra S, Carrión J, Anderson C, Alonso C, Sacks D, Soto M.
    Infect Immun; 2005 Sep 28; 73(9):5842-52. PubMed ID: 16113303
    [Abstract] [Full Text] [Related]

  • 20. Dendritic cells are responsible for the capacity of CpG oligodeoxynucleotides to act as an adjuvant for protective vaccine immunity against Leishmania major in mice.
    Shah JA, Darrah PA, Ambrozak DR, Turon TN, Mendez S, Kirman J, Wu CY, Glaichenhaus N, Seder RA.
    J Exp Med; 2003 Jul 21; 198(2):281-91. PubMed ID: 12874261
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.